Exact Mass: 500.169378
Exact Mass Matches: 500.169378
Found 500 metabolites which its exact mass value is equals to given mass value 500.169378
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nocardicin A
C23H24N4O9 (500.15432139999996)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
(S)-N-[3-(3,4-Methylenedioxyphenyl)-2-(acetylthio)methyl-1-oxoprolyl]-(S)-alanine benzyl ester
C25H28N2O7S (500.16171380000003)
Nocardicin B
C23H24N4O9 (500.15432139999996)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Fluticasone propionate
C25H31F3O5S (500.18441920000004)
Fluticasone propionate, a medium-potency synthetic corticosteroid, is used topically to relieve inflammatory and pruritic symptoms of dermatoses and psoriasis, intranasally to manage symptoms of allergic and non-allergic rhinitis, and orally for the treatment of asthma. Fluticasone propionate binds to the glucocorticoid receptor. Unbound corticosteroids cross the membranes of cells such as mast cells and eosinophils, binding with high affinity to glucocorticoid receptors (GR). The results include alteration of transcription and protein synthesis, a decreased release of leukocytic acid hydrolases, reduction in fibroblast proliferation, prevention of macrophage accumulation at inflamed sites, reduction of collagen deposition, interference with leukocyte adhesion to the capillary wall, reduction of capillary membrane permeability and subsequent edema, reduction of complement components, inhibition of histamine and kinin release, and interference with the formation of scar tissue. In the management of asthma, the glucocorticoid receptor complexes down-regulates proinflammatory mediators such as interleukin-(IL)-1, 3, and 5, and up-regulates anti-inflammatory mediators such as IκB (inhibits NF-κB). Corticosteroids are the most effective anti-inflammatory therapy for allergic diseases. They are believed to inhibit T helper cell type 2 (TH2 T-cell) activation through increased immunoregulatory T cell (CD4+CD25+) suppression (PMID: 15316506). Fluticasone propionate is marketed under the brand name Flixotide and Flixonase by Allen & Hanburys, and Flovent and Flonase by GlaxoSmithKline. Fluticasone propionate is only found in individuals that have used or taken this drug. Hanburys and Flovent and Flonase by GlaxoSmithKline.; Fluticasone propionate is a potent glucocorticoid often prescribed as treatment for asthma and allergic rhinitis. It is marketed with the brand name Flixotide and Flixonase by Allen & Fluticasone is a potent glucocorticoid often prescribed as treatment for asthma and allergic rhinitis. D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Austin
Austin is a mycotoxin produced by the food storage mould (Aspergillus ustus). These are sesquiterpenes containing a lactone ring. Mycotoxin production by the food storage mould (Aspergillus ustus).
Isoaustin
Isoaustin is a mycotoxin from of Penicillium diversu
Artonol C
Artonol C is found in breadfruit. Artonol C is a constituent of the bark of Artocarpus communis (breadfruit) Constituent of the bark of Artocarpus communis (breadfruit). Artonol C is found in breadfruit and fruits.
Orcein
Once used as a food colouring but now banned throughout the EC Cudbear is a dye extracted from orchil lichens that produces colours in the purple range. It can be used to dye wool and silk, without the use of mordant. Cudbear was the first dye to be invented in modern times, and one of the few dyes to be credited to a named individual. Orcinol is extracted from archil lichen, Rocella tinctoria. It is then converted to orcein by ammonia and air. Orcein is a reddish-brown dye, orchil is a purple-blue dye. Orcein is also used as a stain in microscopy to visualize elastic fibers,Hepatitis B surface antigens and copper associated proteins. It is a mixture of phenoxazone derivates - hydroxyorceins, aminoorceins, and aminoorceinimines.
Lyoniresinol 9'-sulfate
C22H28O11S (500.13522580000006)
Lyoniresinol 9-sulfate is found in green vegetables. Lyoniresinol 9-sulfate is a constituent of the roots of Polygonum cuspidatum (Japanese knotweed).
S)-2-(5(((1,2-Dihydro-3-methyl-1-oxobenzo(F)quinazolin-9-YL)methyl)amino)1-oxo-2-isoindolinyl)glutaric acid
Baohuoside II
C26H28O10 (500.16823880000004)
L-Tyrosine, N-(2-(methoxycarbonyl)phenyl)-O-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)-
(E)-N-(2-(((3-(4-Chlorophenyl)allyl)(methyl)amino)methyl)phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide
C26H29ClN2O4S (500.15364640000007)
Nocardicin A
C23H24N4O9 (500.15432139999996)
Rolapitant
Simotinib
C25H26ClFN4O4 (500.16265180000005)
Ikarisoside A
C26H28O10 (500.16823880000004)
Baohuoside II is a natural product found in Epimedium grandiflorum, Epimedium diphyllum, and other organisms with data available. IKarisoside A (Icarisoside-A) is a natural flavonol glycoside and has anti-inflammatory properties. IKarisoside A (Icarisoside-A) is a natural flavonol glycoside and has anti-inflammatory properties.
Artonol C
1,4,5-trihydroxynaphthalene 1,4-di-O-beta-D-glucopyranoside|5-hydroxynaphthalene-1,4-di-O-beta-D-glucopyranoside|juglanoside F
(E)-2-(6-(bis(4-hydroxyphenyl)methylene)-5-(4-hydroxyphenyl)cyclohexa-2,4-dienylidene)-1-(4-hydroxyphenyl)ethanone|selaginellin G
2-((Z)-hepta-5-en-1,3-diynyl)tetrahydrofuran-2-beta-D-glucopyranosyl(1->2)-beta-D-glucopyranoside|panaxfurayne B
O-Rutinoside-3-(3-Hydroxypropyl)phthalide|Pedirutinoside
5-[(1E)-2-(4beta-D-glucopyranosyloxyphenyl)ethenyl]-4,7-dimethoxy-3-methyl-2H-1-benzopyran-2-one
C26H28O10 (500.16823880000004)
Guibourtinidol-(4alpha->2)-3,5,3,4-tetrahydroxystilbene
(6-trans-p-coumaroyl)-3-O-beta-D-glucopyranosyl-(5-acetyl)-2-deoxy-D-ribonic acid
1,4,5-trihydroxynaphthalene 1,5-di-O-beta-D-glucopyranoside|juglanoside G
(1R,2S,4S,5S,6R,7R,9S,10S)-1,2,9,15-tetraacetoxy-4,6-dihydroxy-8-oxodihydro-beta-agarofuran
Haploperoside C
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.543 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.542
Fluticasone propionate
C25H31F3O5S (500.18441920000004)
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
6-methoxy-7-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-2-one
C22H28O13_3-[6-({6-O-[(2R,3R,4R)-3,4-Dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranosyl}oxy)-1-benzofuran-5-yl]propanoic acid
6-methoxy-7-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-2-one
Fluticasone
C25H31F3O5S (500.18441920000004)
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents CONFIDENCE standard compound; INTERNAL_ID 2831 D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Cys Cys Glu Phe
Cys Cys Phe Glu
Cys Cys Ile Tyr
C21H32N4O6S2 (500.17631719999997)
Cys Cys Leu Tyr
C21H32N4O6S2 (500.17631719999997)
Cys Cys Tyr Ile
C21H32N4O6S2 (500.17631719999997)
Cys Cys Tyr Leu
C21H32N4O6S2 (500.17631719999997)
Cys Asp Thr Tyr
C20H28N4O9S (500.15769180000007)
Cys Asp Tyr Thr
C20H28N4O9S (500.15769180000007)
Cys Glu Cys Phe
Cys Glu Phe Cys
Cys Glu Ser Tyr
C20H28N4O9S (500.15769180000007)
Cys Glu Tyr Ser
C20H28N4O9S (500.15769180000007)
Cys Phe Cys Glu
Cys Phe Glu Cys
Cys Phe Met Thr
C21H32N4O6S2 (500.17631719999997)
Cys Phe Thr Met
C21H32N4O6S2 (500.17631719999997)
Cys His Asn Gln
Cys His Gln Asn
Cys Ile Cys Tyr
C21H32N4O6S2 (500.17631719999997)
Cys Ile Tyr Cys
C21H32N4O6S2 (500.17631719999997)
Cys Leu Cys Tyr
C21H32N4O6S2 (500.17631719999997)
Cys Leu Tyr Cys
C21H32N4O6S2 (500.17631719999997)
Cys Met Phe Thr
C21H32N4O6S2 (500.17631719999997)
Cys Met Thr Phe
C21H32N4O6S2 (500.17631719999997)
Cys Asn His Gln
Cys Asn Gln His
Cys Gln His Asn
Cys Gln Asn His
Cys Ser Glu Tyr
C20H28N4O9S (500.15769180000007)
Cys Ser Tyr Glu
C20H28N4O9S (500.15769180000007)
Cys Thr Asp Tyr
C20H28N4O9S (500.15769180000007)
Cys Thr Phe Met
C21H32N4O6S2 (500.17631719999997)
Cys Thr Met Phe
C21H32N4O6S2 (500.17631719999997)
Cys Thr Tyr Asp
C20H28N4O9S (500.15769180000007)
Cys Tyr Cys Ile
C21H32N4O6S2 (500.17631719999997)
Cys Tyr Cys Leu
C21H32N4O6S2 (500.17631719999997)
Cys Tyr Asp Thr
C20H28N4O9S (500.15769180000007)
Cys Tyr Glu Ser
C20H28N4O9S (500.15769180000007)
Cys Tyr Ile Cys
C21H32N4O6S2 (500.17631719999997)
Cys Tyr Leu Cys
C21H32N4O6S2 (500.17631719999997)
Cys Tyr Ser Glu
C20H28N4O9S (500.15769180000007)
Cys Tyr Thr Asp
C20H28N4O9S (500.15769180000007)
Asp Cys Thr Tyr
C20H28N4O9S (500.15769180000007)
Asp Cys Tyr Thr
C20H28N4O9S (500.15769180000007)
Asp Asp Asp His
Asp Asp His Asp
Asp Glu His Thr
C19H28N6O10 (500.18668279999997)
Asp Glu Thr His
C19H28N6O10 (500.18668279999997)
Asp Phe Gly Tyr
Asp Phe Tyr Gly
Asp Gly Phe Tyr
Asp Gly Tyr Phe
Asp His Asp Asp
Asp His Glu Thr
C19H28N6O10 (500.18668279999997)
Asp His Thr Glu
C19H28N6O10 (500.18668279999997)
Asp Thr Cys Tyr
C20H28N4O9S (500.15769180000007)
Asp Thr Glu His
C19H28N6O10 (500.18668279999997)
Asp Thr His Glu
C19H28N6O10 (500.18668279999997)
Asp Thr Tyr Cys
C20H28N4O9S (500.15769180000007)
Asp Tyr Cys Thr
C20H28N4O9S (500.15769180000007)
Asp Tyr Phe Gly
Asp Tyr Gly Phe
Asp Tyr Thr Cys
C20H28N4O9S (500.15769180000007)
Glu Cys Cys Phe
Glu Cys Phe Cys
Glu Cys Ser Tyr
C20H28N4O9S (500.15769180000007)
Glu Cys Tyr Ser
C20H28N4O9S (500.15769180000007)
Glu Asp His Thr
C19H28N6O10 (500.18668279999997)
Glu Asp Thr His
C19H28N6O10 (500.18668279999997)
Glu Glu His Ser
C19H28N6O10 (500.18668279999997)
Glu Glu Ser His
C19H28N6O10 (500.18668279999997)
Glu Phe Cys Cys
Glu His Asp Thr
C19H28N6O10 (500.18668279999997)
Glu His Glu Ser
C19H28N6O10 (500.18668279999997)
Glu His Ser Glu
C19H28N6O10 (500.18668279999997)
Glu His Thr Asp
C19H28N6O10 (500.18668279999997)
Glu Ser Cys Tyr
C20H28N4O9S (500.15769180000007)
Glu Ser Glu His
C19H28N6O10 (500.18668279999997)
Glu Ser His Glu
C19H28N6O10 (500.18668279999997)
Glu Ser Tyr Cys
C20H28N4O9S (500.15769180000007)
Glu Thr Asp His
C19H28N6O10 (500.18668279999997)
Glu Thr His Asp
C19H28N6O10 (500.18668279999997)
Glu Tyr Cys Ser
C20H28N4O9S (500.15769180000007)
Glu Tyr Ser Cys
C20H28N4O9S (500.15769180000007)
Phe Cys Cys Glu
Phe Cys Glu Cys
Phe Cys Met Thr
C21H32N4O6S2 (500.17631719999997)
Phe Cys Thr Met
C21H32N4O6S2 (500.17631719999997)
Phe Asp Gly Tyr
Phe Asp Tyr Gly
Phe Glu Cys Cys
Phe Gly Asp Tyr
Phe Gly Tyr Asp
Phe Met Cys Thr
C21H32N4O6S2 (500.17631719999997)
Phe Met Thr Cys
C21H32N4O6S2 (500.17631719999997)
Phe Thr Cys Met
C21H32N4O6S2 (500.17631719999997)
Phe Thr Met Cys
C21H32N4O6S2 (500.17631719999997)
Phe Tyr Asp Gly
Phe Tyr Gly Asp
Gly Asp Phe Tyr
Gly Asp Tyr Phe
Gly Phe Asp Tyr
Gly Phe Tyr Asp
Gly Met Met Tyr
C21H32N4O6S2 (500.17631719999997)
Gly Met Tyr Met
C21H32N4O6S2 (500.17631719999997)
Gly Tyr Asp Phe
Gly Tyr Phe Asp
Gly Tyr Met Met
C21H32N4O6S2 (500.17631719999997)
His Cys Asn Gln
His Cys Gln Asn
His Asp Asp Asp
His Asp Glu Thr
C19H28N6O10 (500.18668279999997)
His Asp Thr Glu
C19H28N6O10 (500.18668279999997)
His Glu Asp Thr
C19H28N6O10 (500.18668279999997)
His Glu Glu Ser
C19H28N6O10 (500.18668279999997)
His Glu Ser Glu
C19H28N6O10 (500.18668279999997)
His Glu Thr Asp
C19H28N6O10 (500.18668279999997)
His Asn Cys Gln
His Asn Gln Cys
His Gln Cys Asn
His Gln Asn Cys
His Ser Glu Glu
C19H28N6O10 (500.18668279999997)
His Thr Asp Glu
C19H28N6O10 (500.18668279999997)
His Thr Glu Asp
C19H28N6O10 (500.18668279999997)
Ile Cys Cys Tyr
C21H32N4O6S2 (500.17631719999997)
Ile Cys Tyr Cys
C21H32N4O6S2 (500.17631719999997)
Ile Tyr Cys Cys
C21H32N4O6S2 (500.17631719999997)
Leu Cys Cys Tyr
C21H32N4O6S2 (500.17631719999997)
Leu Cys Tyr Cys
C21H32N4O6S2 (500.17631719999997)
Leu Tyr Cys Cys
C21H32N4O6S2 (500.17631719999997)
Met Cys Phe Thr
C21H32N4O6S2 (500.17631719999997)
Met Cys Thr Phe
C21H32N4O6S2 (500.17631719999997)
Met Phe Cys Thr
C21H32N4O6S2 (500.17631719999997)
Met Phe Thr Cys
C21H32N4O6S2 (500.17631719999997)
Met Gly Met Tyr
C21H32N4O6S2 (500.17631719999997)
Met Gly Tyr Met
C21H32N4O6S2 (500.17631719999997)
Met Met Gly Tyr
C21H32N4O6S2 (500.17631719999997)
Met Met Tyr Gly
C21H32N4O6S2 (500.17631719999997)
Met Ser Thr Tyr
Met Ser Tyr Thr
Met Thr Cys Phe
C21H32N4O6S2 (500.17631719999997)
Met Thr Phe Cys
C21H32N4O6S2 (500.17631719999997)
Met Thr Ser Tyr
Met Thr Tyr Ser
Met Tyr Gly Met
C21H32N4O6S2 (500.17631719999997)
Met Tyr Met Gly
C21H32N4O6S2 (500.17631719999997)
Met Tyr Ser Thr
Met Tyr Thr Ser
Asn Cys His Gln
Asn Cys Gln His
Asn His Cys Gln
Asn His Gln Cys
Asn Gln Cys His
Asn Gln His Cys
Gln Cys His Asn
Gln Cys Asn His
Gln His Cys Asn
Gln His Asn Cys
Gln Asn Cys His
Gln Asn His Cys
Ser Cys Glu Tyr
C20H28N4O9S (500.15769180000007)
Ser Cys Tyr Glu
C20H28N4O9S (500.15769180000007)
Ser Glu Cys Tyr
C20H28N4O9S (500.15769180000007)
Ser Glu Glu His
C19H28N6O10 (500.18668279999997)
Ser Glu His Glu
C19H28N6O10 (500.18668279999997)
Ser Glu Tyr Cys
C20H28N4O9S (500.15769180000007)
Ser His Glu Glu
C19H28N6O10 (500.18668279999997)
Ser Met Thr Tyr
Ser Met Tyr Thr
Ser Thr Met Tyr
Ser Thr Tyr Met
Ser Tyr Cys Glu
C20H28N4O9S (500.15769180000007)
Ser Tyr Glu Cys
C20H28N4O9S (500.15769180000007)
Ser Tyr Met Thr
Ser Tyr Thr Met
Thr Cys Asp Tyr
C20H28N4O9S (500.15769180000007)
Thr Cys Phe Met
C21H32N4O6S2 (500.17631719999997)
Thr Cys Met Phe
C21H32N4O6S2 (500.17631719999997)
Thr Cys Tyr Asp
C20H28N4O9S (500.15769180000007)
Thr Asp Cys Tyr
C20H28N4O9S (500.15769180000007)
Thr Asp Glu His
C19H28N6O10 (500.18668279999997)
Thr Asp His Glu
C19H28N6O10 (500.18668279999997)
Thr Asp Tyr Cys
C20H28N4O9S (500.15769180000007)
Thr Glu Asp His
C19H28N6O10 (500.18668279999997)
Thr Glu His Asp
C19H28N6O10 (500.18668279999997)
Thr Phe Cys Met
C21H32N4O6S2 (500.17631719999997)
Thr Phe Met Cys
C21H32N4O6S2 (500.17631719999997)
Thr His Asp Glu
C19H28N6O10 (500.18668279999997)
Thr His Glu Asp
C19H28N6O10 (500.18668279999997)
Thr Met Cys Phe
C21H32N4O6S2 (500.17631719999997)
Thr Met Phe Cys
C21H32N4O6S2 (500.17631719999997)
Thr Met Ser Tyr
Thr Met Tyr Ser
Thr Ser Met Tyr
Thr Ser Tyr Met
Thr Tyr Cys Asp
C20H28N4O9S (500.15769180000007)
Thr Tyr Asp Cys
C20H28N4O9S (500.15769180000007)
Thr Tyr Met Ser
Thr Tyr Ser Met
Tyr Cys Cys Ile
C21H32N4O6S2 (500.17631719999997)
Tyr Cys Cys Leu
C21H32N4O6S2 (500.17631719999997)
Tyr Cys Asp Thr
C20H28N4O9S (500.15769180000007)
Tyr Cys Glu Ser
C20H28N4O9S (500.15769180000007)
Tyr Cys Ile Cys
C21H32N4O6S2 (500.17631719999997)
Tyr Cys Leu Cys
C21H32N4O6S2 (500.17631719999997)
Tyr Cys Ser Glu
C20H28N4O9S (500.15769180000007)
Tyr Cys Thr Asp
C20H28N4O9S (500.15769180000007)
Tyr Asp Cys Thr
C20H28N4O9S (500.15769180000007)
Tyr Asp Phe Gly
Tyr Asp Gly Phe
Tyr Asp Thr Cys
C20H28N4O9S (500.15769180000007)
Tyr Glu Cys Ser
C20H28N4O9S (500.15769180000007)
Tyr Glu Ser Cys
C20H28N4O9S (500.15769180000007)
Tyr Phe Asp Gly
Tyr Phe Gly Asp
Tyr Gly Asp Phe
Tyr Gly Phe Asp
Tyr Gly Met Met
C21H32N4O6S2 (500.17631719999997)
Tyr Ile Cys Cys
C21H32N4O6S2 (500.17631719999997)
Tyr Leu Cys Cys
C21H32N4O6S2 (500.17631719999997)
Tyr Met Gly Met
C21H32N4O6S2 (500.17631719999997)
Tyr Met Met Gly
C21H32N4O6S2 (500.17631719999997)
Tyr Met Ser Thr
Tyr Met Thr Ser
Tyr Ser Cys Glu
C20H28N4O9S (500.15769180000007)
Tyr Ser Glu Cys
C20H28N4O9S (500.15769180000007)
Tyr Ser Met Thr
Tyr Ser Thr Met
Tyr Thr Cys Asp
C20H28N4O9S (500.15769180000007)
Tyr Thr Asp Cys
C20H28N4O9S (500.15769180000007)
Tyr Thr Met Ser
Tyr Thr Ser Met
Flutide
C25H31F3O5S (500.18441920000004)
KN-93
C26H29ClN2O4S (500.15364640000007)
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Orcein
D004396 - Coloring Agents
Lyoniresinol 9'-sulfate
C22H28O11S (500.13522580000006)
rolapitant
A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Rolapitant (SCH619734) is a potent, selective, long-acting and orally active neurokinin 1 (NK1) receptor antagonist with a Ki of 0.66 nM. Rolapitant does not interact with CYP3A4. Rolapitant shows potent anti-emetic activity in a ferret emesis model[1][2].
1,4-PHENYLENEBIS[[4-(4-AMINOPHENOXY)PHENYL]METHANONE]
[4,5,8-triacetyloxy-6-(1-acetyloxy-4-methylpent-3-enyl)naphthalen-1-yl] acetate
C26H28O10 (500.16823880000004)
4-hexyl-2-(4-hexyl-5-thiophen-2-yl-1,3-thiazol-2-yl)-5-thiophen-2-yl-1,3-thiazole
C26H32N2S4 (500.14482319999996)
5-(4-CHLOROPHENYL)-1-(2,4-DICHLOROPHENYL)-4-METHYLPYRAZOLE-3-CARBOXYLICACID
C27H34BrO2P (500.14796540000003)
(6R,7R)-3-Hydroxy-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenyl methyl ester
Benzoic acid, 4-(((2,3-dihydro-6-((2-methylpropyl)(2-thiazolylsulfonyl)amino)-1H-inden-5-yl)oxy)methyl)-3-methyl-
5-hydroxy-2-methylchromone-7-O-rutinoside
A disaccharide derivative that consists of 5-hydroxy-2-methylchromone substituted by a rutinosyl group at position 7 via a glycosidic linkage. Isolated from Crossosoma bigelovii, it exhibits antineoplastic activity.
Managlinat dialanetil
C21H33N4O6PS (500.18583280000007)
C471 - Enzyme Inhibitor
1843U89;(2S)-2-(5-{[(3-Methyl-1-oxo-1,2-dihydrobenzo[f]quinazolin-9-yl)me thyl]amino}-1-oxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioic acid
S)-2-(5(((1,2-Dihydro-3-methyl-1-oxobenzo(F)quinazolin-9-YL)methyl)amino)1-oxo-2-isoindolinyl)glutaric acid
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D000970 - Antineoplastic Agents
(1S,3S)-3-ethyl-3,5,10,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-azaniumyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(2S)-2-amino-4-[4-[(E)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-hydroxycarbonimidoyl]phenoxy]butanoic acid
C23H24N4O9 (500.15432139999996)
(3S,alphaR)-3-[[[4-[(R)-3-Amino-3-carboxypropoxy]phenyl]-[(Z)-hydroxyimino]acetyl]amino]-alpha-(4-hydroxyphenyl)-2-oxo-1-azetidineacetic acid
C23H24N4O9 (500.15432139999996)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
(2S)-3-hydroxy-2-[[1-[[(2R)-2-[(1R)-2-methoxy-2-oxo-1-phenylethyl]piperidine-1-carbonyl]oxymethyl]pyridin-1-ium-3-carbonyl]amino]propanoic acid
2-[cyclopentyl-[1-oxo-2-(5-thiophen-2-yl-2-tetrazolyl)ethyl]amino]-N-(2-oxolanylmethyl)-2-thiophen-2-ylacetamide
2-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxo-1-imidazolidinyl]-N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide
2-(4-morpholinyl)-9-(3-thiophenyl)-N-[[6-(trifluoromethyl)-1H-benzimidazol-2-yl]methyl]-6-purinamine
C22H19F3N8OS (500.13545600000003)
6,9-difluoro-11-hydroxy-17-(3-hydroxy-2-oxopropyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioic acid S-(fluoromethyl) ester
C25H31F3O5S (500.18441920000004)
N-[(2R,3R)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
N-[(2R,3S)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
N-[[(4R,5R)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5R)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4S,5R)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5S)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclohexylacetamide
N-[(2S,3R)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
N-[(2R,3S)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
N-[[(4S,5S)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4S,5S)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4S,5R)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5S)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[(2S,3S)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
N-[(2S,3R)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
N-[(2S,3S)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
1,2-diacetyl-3-[beta-D-glucosyl-(1->6)-beta-D-galactosyl]-sn-glycerol
C19H32O15 (500.17411219999997)
(2S)-2-ammonio-4-{4-[(1Z)-2-({(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}amino)-N-hydroxy-2-oxoethanimidoyl]phenoxy}butanoate
C23H24N4O9 (500.15432139999996)
9-(2-Carboxy-4-isothiocyanatophenyl)-3,6-bis(diethylamino)xanthylium
(2S,3S,4S,5R)-6-[7-carbamoyl-5-hydroxy-1-(4-phenylbutan-2-yl)indol-6-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
(2S,3S,4S,5R)-6-[7-carbamoyl-6-hydroxy-1-(4-phenylbutan-2-yl)indol-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
Fluticasone propionate (Flonase, Veramyst)
C25H31F3O5S (500.18441920000004)
[2-Acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] acetate
C19H32O15 (500.17411219999997)
Isonocardicin A
C23H24N4O9 (500.15432139999996)
A nocardicin in which the beta-lactam moiety is substituted at position 1 by a carboxy(4-hydroxyphenyl)methyl group and at position 3 by a [(2Z)-2-(hydroxyimino)-2-(4-hydroxyphenyl)acetyl]nitrilo group in which the phenolic hydroxy group is substituted by a (3S)-3-amino-3-carboxypropyl group.
13-deoxycarminomycin(1+)
An anthracyline cation that is the conjugate acid of 13-deoxycarminomycin, obtained by protonation of the amino group. Major microspecies at pH 7.3
isonocardicin A zwitterion
C23H24N4O9 (500.15432139999996)
An L-alpha-amino acid zwitterion resulting from the transfer of a proton from the carboxy group to the amino group of isonocardicin A.
ELN-441958
ELN-441958 is a potent, neutral, competitive and selective bradykinin B1 receptor antagonist with a Ki of 0.26 nM against native human bradykinin B1 receptor. ELN-441958 has high oral bioavailability, and has low CNS exposure in the mouse[1].
4-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,2-diol
(12r)-3,10,17-trihydroxy-7,7,21,21-tetramethyl-12-(prop-1-en-2-yl)-8,20,26-trioxahexacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁶,²⁵.0¹⁹,²⁴]hexacosa-1(14),2,4(9),5,10,16,18,22,24-nonaen-15-one
2-(3,5-diformyl-2,4,6-trihydroxyphenyl)-5,7-dihydroxy-3-isopropyl-4-(2-methylpropyl)-3,4-dihydro-2h-1-benzopyran-6,8-dicarbaldehyde
C26H28O10 (500.16823880000004)
methyl (3r)-4-{6-[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]-1,5-dihydroxy-9,10-dioxoanthracen-2-yl}-3-hydroxy-3-methylbutanoate
C26H28O10 (500.16823880000004)
(11s,12r)-6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-triene-8,11-diol
(8r,10s)-10-{[(2r,3r,4r,5r,6s)-4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl]oxy}-1,8,11-trihydroxy-8-methyl-9,10-dihydro-7h-tetracene-5,12-dione
C26H28O10 (500.16823880000004)
4,7-dimethoxy-3-methyl-5-[(1e)-2-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethenyl]chromen-2-one
C26H28O10 (500.16823880000004)
5-[(2s,3s)-7-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]-6-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1-benzofuran-3-yl]benzene-1,3-diol
(1e,2r,3r)-3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol
(4r,7r,7ar)-3,7a-dibenzyl-4-hydroxy-4,7-diphenyl-6,7-dihydro-1-benzofuran-2,5-dione
(9r)-8-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-9-[(4-methoxyphenyl)methyl]-9h-xanthene-2,3,6-triol
(2s,3r,4s,5s,6r)-2-[(3-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
5-[(2r,3s)-8-formyl-5,7-dihydroxy-3-isopropyl-6-(3-methylbutanoyl)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde
C26H28O10 (500.16823880000004)
4-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,3-diol
7-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)-3-methyloxolan-2-yl]oxy}methyl)-3,4,5-trihydroxy-3-methyloxan-2-yl]oxy}-6-hydroxychromen-2-one
11,12,16-trimethyl (1r,12r,13r,16r,23r)-12-hydroxy-6,8-dioxa-11,20-diazahexacyclo[14.6.1.0¹,¹³.0²,¹⁰.0⁵,⁹.0²⁰,²³]tricosa-2(10),3,5(9),17-tetraene-11,12,16-tricarboxylate
7-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-6-methoxychromen-2-one
16,18-dimethyl 18-hydroxy-23-methoxy-11,13,20-trioxa-3,16-diazaoctacyclo[15.6.2.0¹,¹⁹.0²,⁶.0³,²¹.0⁶,¹⁷.0⁷,¹⁵.0¹⁰,¹⁴]pentacosa-7(15),8,10(14)-triene-16,18-dicarboxylate
12-(acetyloxy)-6-chloro-14,15-dihydroxy-2,11,15-trimethyl-7-methylidene-3-oxo-4,18-dioxatetracyclo[8.7.1.0¹,⁵.0¹¹,¹⁶]octadecan-17-yl acetate
C24H33ClO9 (500.18129980000003)
3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol
[(2s,3s,4s,5r)-3,4,5-trihydroxy-6-[(2s)-3-(octanoyloxy)-2-(propanoyloxy)propoxy]oxan-2-yl]methanesulfonic acid
C20H36O12S (500.19273760000004)
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one
C26H28O10 (500.16823880000004)
6,7-dihydroxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 4-hydroxybenzoate
(4s,5s,11s,12r)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol
12alpha-Hydroxyevodol
C26H28O10 (500.16823880000004)
{"Ingredient_id": "HBIN000707","Ingredient_name": "12alpha-Hydroxyevodol","Alias": "12alpha-hydroxyevodol; 12\u03b1-hydroxyevodol","Ingredient_formula": "C26H28O10","Ingredient_Smile": "CC1(C2=C(C(=O)C3(C(C24COC(=O)CC4O1)CC(C5(C36C(O6)C(=O)OC5C7=COC=C7)C)O)C)O)C","Ingredient_weight": "500.5 g/mol","OB_score": "19.40751811","CAS_id": "NA","SymMap_id": "SMIT01183;SMIT15841","TCMID_id": "31192;10117","TCMSP_id": "MOL003976","TCM_ID_id": "19312","PubChem_id": "129317030","DrugBank_id": "NA"}
5-methylcoumarin-4-cellobioside
{"Ingredient_id": "HBIN011802","Ingredient_name": "5-methylcoumarin-4-cellobioside","Alias": "NA","Ingredient_formula": "C22H28O13","Ingredient_Smile": "CC1=C2C(=CC=C1)OC(=O)C=C2OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)CO)O)O)O)O)O","Ingredient_weight": "500.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14248","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "196631","DrugBank_id": "NA"}
5-methylcoumarin-4-gentiobioside
{"Ingredient_id": "HBIN011803","Ingredient_name": "5-methylcoumarin-4-gentiobioside","Alias": "NA","Ingredient_formula": "C22H28O13","Ingredient_Smile": "CC1=C2C(=CC=C1)OC(=O)C=C2OC3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)O","Ingredient_weight": "500.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14249","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "3080987","DrugBank_id": "NA"}
[(1s,2s,4s,5r,6s,7s,9r,12r)-4,5,7-tris(acetyloxy)-2,12-dihydroxy-2,10,10-trimethyl-8-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-6-yl]methyl acetate
12-(acetyloxy)-9-(chloromethyl)-2,3-dihydroxy-4,13,18-trimethyl-5-oxo-6,17-dioxatetracyclo[11.5.0.0³,⁷.0¹⁶,¹⁸]octadec-8-en-14-yl acetate
C24H33ClO9 (500.18129980000003)
(1r,2s,3r)-2-(3,5-dihydroxyphenyl)-1-[(r)-ethoxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1h-indene-4,6-diol
(1z,2s,3s)-3-(3,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol
(2r,3r,4r)-4-{2-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4,6-dihydroxyphenyl}-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol
(2r)-2-amino-4-{4-[(e)-{[(3s)-1-[(r)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid
C23H24N4O9 (500.15432139999996)
5-[8-formyl-5,7-dihydroxy-3-isopropyl-6-(3-methylbutanoyl)-3,4-dihydro-2h-1-benzopyran-2-yl]-2,4,6-trihydroxybenzene-1,3-dicarbaldehyde
C26H28O10 (500.16823880000004)
(2r,3r,4s)-2-(3,5-diformyl-2,4,6-trihydroxyphenyl)-5,7-dihydroxy-3-isopropyl-4-(2-methylpropyl)-3,4-dihydro-2h-1-benzopyran-6,8-dicarbaldehyde
C26H28O10 (500.16823880000004)
(2s,3r,4s,5s,6r)-2-[(4-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one
C26H28O10 (500.16823880000004)
4-[3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,3-diol
(5r,5ar,6as,6bs,10ar,11r,12as,12bs,12cs)-10a-chloro-5a,11-dihydroxy-3,3',4',6b,12c-pentamethyl-2,6,6a,10,11,12,12a,12b-octahydro-1h-spiro[cyclohexa[j]aceanthrylene-5,2'-furan]-4,5',7-trione
C28H33ClO6 (500.19655480000006)
(2s)-2-amino-4-{4-[(z)-{[(3s)-1-[(s)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid
C23H24N4O9 (500.15432139999996)
1-(3,5-dihydroxy-2-{[(4-methoxy-4-oxobutan-2-yl)oxy]carbonyl}phenyl)propan-2-yl 4-hydroxy-3-[(3-hydroxybutanoyl)oxy]butanoate
(2s,3r,4s,5s,6r)-2-[(5-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3s,4s)-2-(3,5-diformyl-2,4,6-trihydroxyphenyl)-5,7-dihydroxy-3-isopropyl-4-(2-methylpropyl)-3,4-dihydro-2h-1-benzopyran-6,8-dicarbaldehyde
C26H28O10 (500.16823880000004)
7-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-methoxychromen-2-one
(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5s,6r)-2-{[(2r)-2-[(5z)-hept-5-en-1,3-diyn-1-yl]oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[4'-methoxy-4-(4-methoxyphenyl)-[1,1'-biphenyl]-2,6-diyl]oxy}oxane-3,4,5-triol
C26H28O10 (500.16823880000004)
2-(3,4-dihydroxyphenyl)ethyl 1-hydroxy-9-[2-(4-hydroxyphenyl)ethoxy]-6-oxo-1h,4ah,5h,8h,9h,9ah-pyrano[3,4-d]oxepine-4-carboxylate
C26H28O10 (500.16823880000004)
6-(acetyloxy)-2,4',5-trihydroxy-4-(4-hydroxyphenyl)-[1,1'-biphenyl]-3-yl 3-phenylpropanoate
4-{2-[2-(3,4-dihydroxyphenyl)ethenyl]-4,6-dihydroxyphenyl}-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol
(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5s,6r)-2-{[(2r)-2-[(5e)-hept-5-en-1,3-diyn-1-yl]oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
[4,5,7-tris(acetyloxy)-2,12-dihydroxy-2,10,10-trimethyl-8-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-6-yl]methyl acetate
2,4-dihydroxy-7-(4-hydroxy-2-methoxy-6-methylphenyl)-9-methoxy-12,12-dimethyltetracene-5,6,11-trione
(1r,4s,5r,6s,7r,8s,9s)-4,5-dihydroxy-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,10-dioxatricyclo[5.3.1.0⁴,⁸]undecan-6-yl 4-hydroxybenzoate
(7s,9r)-6,9-dihydroxy-2-methoxy-9-methyl-7-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-8,10-dihydro-7h-tetracene-5,12-dione
C26H28O10 (500.16823880000004)
4,5-dihydroxy-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,10-dioxatricyclo[5.3.1.0⁴,⁸]undecan-6-yl 4-hydroxybenzoate
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-3-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one
C26H28O10 (500.16823880000004)
4,7-dimethoxy-3-methyl-5-[2-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethenyl]chromen-2-one
C26H28O10 (500.16823880000004)
6,9-dihydroxy-2-methoxy-9-methyl-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-8,10-dihydro-7h-tetracene-5,12-dione
C26H28O10 (500.16823880000004)
(1e,2s,3s)-3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol
4-[3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,2-diol
(11r,12s)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol
6-methoxy-7-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]chromen-2-one
2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-n-[2-(methoxycarbonyl)phenyl]-4-(methylsulfanyl)butanimidic acid
(4s,5s,11r,12s)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol
3,11,12-trimethyl (6ar,12r,12ar)-12-hydroxy-10-methoxy-4-[(1e)-3-oxoprop-1-en-1-yl]-1h,2h,5h,6h,12ah-pyrrolo[2,3-n]phenanthridine-3,11,12-tricarboxylate
(1r,2r,5r,6s,10r,11r,12s,14r,15s,16s,17r)-12-(acetyloxy)-6-chloro-14,15-dihydroxy-2,11,15-trimethyl-7-methylidene-3-oxo-4,18-dioxatetracyclo[8.7.1.0¹,⁵.0¹¹,¹⁶]octadecan-17-yl acetate
C24H33ClO9 (500.18129980000003)
6-methoxy-7-{[(2s,3r,4s,5s)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}chromen-2-one
6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1,3(7),8-triene-8,11-diol
3-[(3s)-3-{[(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}butyl]-3h-2-benzofuran-1-one
2-{[4,5-dihydroxy-2-(hydroxymethyl)-6-{[4,5,6-trihydroxy-2-(hydroxymethyl)cyclohex-2-en-1-yl]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
C19H32O15 (500.17411219999997)
11,17-dihydroxy-7,7,20,20-tetramethyl-4-(3-methylbut-2-en-1-yl)-2,6,19,25-tetraoxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²⁴.0¹⁸,²³]pentacosa-1(14),3,5(10),8,11,15(24),16,18(23),21-nonaen-13-one
(2s)-2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-n-[2-(methoxycarbonyl)phenyl]-4-(methylsulfanyl)butanimidic acid
(2r)-n-[(1s,2s)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-{[2-(2-hydroxybenzoyloxy)ethyl]sulfanyl}oxan-2-yl]propyl]pyrrolidine-2-carboximidic acid
(2r,3r,4r)-2-(3,5-diformyl-2,4,6-trihydroxyphenyl)-5,7-dihydroxy-3-isopropyl-4-(2-methylpropyl)-3,4-dihydro-2h-1-benzopyran-6,8-dicarbaldehyde
C26H28O10 (500.16823880000004)
(5r,6r,11s,12r)-6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1,3(7),8-triene-8,11-diol
(1r,2r,5r,6s,10s,11s,12s,14r,15s,16s,17r)-12-(acetyloxy)-6-chloro-14,15-dihydroxy-2,11,15-trimethyl-7-methylidene-3-oxo-4,18-dioxatetracyclo[8.7.1.0¹,⁵.0¹¹,¹⁶]octadecan-17-yl acetate
C24H33ClO9 (500.18129980000003)
(2r,3r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzopyran-4-one
5,13,17,19-tetrahydroxy-22,22-dimethyl-15-oxo-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4(9),5,7,10,13,16,18,20-decaene-6-carboxylic acid
10a-chloro-5a,11-dihydroxy-3,3',4',6b,12c-pentamethyl-2,6,6a,10,11,12,12a,12b-octahydro-1h-spiro[cyclohexa[j]aceanthrylene-5,2'-furan]-4,5',7-trione
C28H33ClO6 (500.19655480000006)
5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol
[(3s,4s,5s)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-hydroxyphenoxy)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl]methyl (2e)-hex-2-enoate
3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzopyran-4-one
(5-{[4,5-dihydroxy-6-(hydroxymethyl)-2-(4-hydroxyphenoxy)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl)methyl hex-2-enoate
(12s)-3,10,17-trihydroxy-7,7,21,21-tetramethyl-12-(prop-1-en-2-yl)-8,20,26-trioxahexacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁶,²⁵.0¹⁹,²⁴]hexacosa-1(14),2,4(9),5,10,16,18,22,24-nonaen-15-one
(1s,2r,3r,4r,7s,8e,12r,13s,14s,16s,18r)-12-(acetyloxy)-9-(chloromethyl)-2,3-dihydroxy-4,13,18-trimethyl-5-oxo-6,17-dioxatetracyclo[11.5.0.0³,⁷.0¹⁶,¹⁸]octadec-8-en-14-yl acetate
C24H33ClO9 (500.18129980000003)
(1s,4ar,5s,6r,7s,7as)-6,7-dihydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 4-hydroxybenzoate
3,11,12-trimethyl 12-hydroxy-10-methoxy-4-(3-oxoprop-1-en-1-yl)-1h,2h,5h,6h,12ah-pyrrolo[2,3-n]phenanthridine-3,11,12-tricarboxylate
(2r)-2-amino-4-{4-[(z)-{[(3s)-1-[(r)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid
C23H24N4O9 (500.15432139999996)
2-[(2-{[2-(hept-5-en-1,3-diyn-1-yl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,2s,3r)-2-(3,5-dihydroxyphenyl)-1-[(s)-ethoxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1h-indene-4,6-diol
8-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-9-[(4-methoxyphenyl)methyl]-9h-xanthene-2,3,6-triol
5-{7-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]-6-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1-benzofuran-3-yl}benzene-1,3-diol
2-amino-4-{4-[(z)-({1-[carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}-c-hydroxycarbonimidoyl)(hydroxyimino)methyl]phenoxy}butanoic acid
C23H24N4O9 (500.15432139999996)
2-amino-4-{4-[({1-[carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}-c-hydroxycarbonimidoyl)(hydroxyimino)methyl]phenoxy}butanoic acid
C23H24N4O9 (500.15432139999996)
2-(3,4-dihydroxyphenyl)ethyl (1r,4as,9s,9as)-1-hydroxy-9-[2-(4-hydroxyphenyl)ethoxy]-6-oxo-1h,4ah,5h,8h,9h,9ah-pyrano[3,4-d]oxepine-4-carboxylate
C26H28O10 (500.16823880000004)
2-[(4-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
4-{[1-(3,5-dihydroxy-2-{[(4-methoxy-4-oxobutan-2-yl)oxy]carbonyl}phenyl)propan-2-yl]oxy}-4-oxobutan-2-yl 3,4-dihydroxybutanoate
7-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)-3-methyloxolan-2-yl]oxy}methyl)-3,4,5-trihydroxy-3-methyloxan-2-yl]oxy}-6-hydroxychromen-2-one
2-(hydroxymethyl)-6-{[4'-methoxy-4-(4-methoxyphenyl)-[1,1'-biphenyl]-2,6-diyl]oxy}oxane-3,4,5-triol
C26H28O10 (500.16823880000004)
(1r,2s,3e)-1-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-3-[(4-hydroxy-3-methoxyphenyl)methylidene]-1,2-dihydroindene-5,6-diol
2-(3,5-dihydroxyphenyl)-1-[ethoxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1h-indene-4,6-diol
16,18-dimethyl (1s,2r,6r,17s,18r,19r,21s,23s)-18-hydroxy-23-methoxy-11,13,20-trioxa-3,16-diazaoctacyclo[15.6.2.0¹,¹⁹.0²,⁶.0³,²¹.0⁶,¹⁷.0⁷,¹⁵.0¹⁰,¹⁴]pentacosa-7(15),8,10(14)-triene-16,18-dicarboxylate
11,17-dihydroxy-7,7,20,20-tetramethyl-10-(3-methylbut-2-en-1-yl)-2,8,19,25-tetraoxahexacyclo[12.11.0.0³,¹².0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosa-1(14),3,5,9,11,15(24),16,18(23),21-nonaen-13-one
2-[(5-hydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
[(3r,4s,5r)-5-{[(2r,3s,4r,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-hydroxyphenoxy)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl]methyl (2e)-hex-2-enoate
5-hydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-en-1-yl)-7-{[(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
C26H28O10 (500.16823880000004)
5-hydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-en-1-yl)-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
C26H28O10 (500.16823880000004)
5-hydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-en-1-yl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
C26H28O10 (500.16823880000004)